search
Back to results

Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study (TBS-COG)

Primary Purpose

Social Cognition in Patients With Schizophrenia

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Magstim® Active TBS
Magstim® Sham TBS
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Social Cognition in Patients With Schizophrenia focused on measuring theta burst stimulation, Social Cognition, Schizophrenia, transcranial magnetic stimulation

Eligibility Criteria

18 Years - 50 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • with a diagnosis of schizophrenia or schizoaffective disorder (DSM-IV MINI R)
  • Having signed a written informed consent
  • 'Lecture Intentionnelle en situation' (LIS) score > 15 or negative 'Positive and Negative Syndrome Scale' (PANSS) score > 15

Exclusion Criteria:

  • Any change in psychotropic drugs (antidepressants, antipsychotics or mood stabilizers) during the two months preceding the inclusion
  • Pregnant or breastfeeding women
  • Subjects with a neurological condition or with epilepsy
  • Subjects with a counter-indication to MRI or Transcranial stimulation (electronic or metal implants)
  • Subjects that refuse to wear earplugs during MRI

Sites / Locations

  • DollfusRecruiting
  • JaafariRecruiting
  • GuillinRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Sham Comparator

Arm Label

TBS-MPC

TBS-CPDLF

TBS-Sham

Arm Description

Intervention with Magstim® Active TBS aiming Medial Prefrontal Cortex in 18 patients with schizophrenia

Intervention with Magstim® Active TBS aiming Dorsolateral Prefrontal Cortex in 18 patients with schizophrenia

Intervention with Magstim® Sham TBS in 25 patients with schizophrenia

Outcomes

Primary Outcome Measures

V-LIS total score

Secondary Outcome Measures

Motor activity measured with an actimeter

Full Information

First Posted
June 2, 2015
Last Updated
March 8, 2022
Sponsor
University Hospital, Caen
Collaborators
University Hospital, Rouen, Centre Hospitalier Universitaire Dijon, Poitiers University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02479919
Brief Title
Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study
Acronym
TBS-COG
Official Title
Treating Social Cognition Impairments in Patients With Schizophrenia With Repetitive Transcranial Magnetic Stimulation (Theta-Burst; TBS); a Multicentric Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 11, 2017 (Actual)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
March 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen
Collaborators
University Hospital, Rouen, Centre Hospitalier Universitaire Dijon, Poitiers University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to test a new treatment of social cognition deficits in patients with schizophrenia or schizoaffective disorder by transcranial magnetic stimulation (theta-burst). The study will also identify clinical, psychomotor and cognitive variables that are the most sensitive to treatment, and estimate the most sensitive treatment target between patients.
Detailed Description
The language understanding of other people is based on linguistic decoding mechanisms (phonological, semantic, syntactic ...) but also more on subtle mechanisms for the recognition of emotions and intentions. Interact with another one requires understanding its language but also to infer emotions and intentions. There are patients with schizophrenia suffering from social cognition disorders that impair social interactions; These patients often have difficulty in extracting the non-verbal emotional content of language and have difficulty inferring the thoughts and intentions of others. Recently, investigators have suggested a link between such deficits and the hypofunction of the medial prefrontal cortex. Transcranial magnetic stimulation is a noninvasive neuromodulation technique that increases or decreases the focal cortical excitability depending on stimulation parameters. This technique is now commonly used as a therapeutic tool. It has been tried with some success in patients with schizophrenia in some indications: To reduce the auditory verbal hallucinations stimulating the temporal cortex More rarely, to reduce the negative symptoms stimulating the dorsolateral prefrontal cortex. So far, the medial prefrontal cortex was not considered as a possible target as the scalp to cortex distance prevent from using conventional stimulation coils. Recently new coils have been developed that permit stimulation of deeper cortical regions. Investigators hypothesize that the use of transcranial magnetic stimulation with a theta burst intermittent protocol known to increase the cortical excitability and aiming the medial prefrontal cortex with a special antenna will improve social interaction capabilities of schizophrenic patients. In this multicentric study, involving 61 patients, investigators plan to assess the social cognition deficits before and after 10 sessions of magnetic stimulation (2 sessions per day for 5 consecutive days) using a neuronavigation system and Magstim® stimulator. In order to assess the specificity of the stimulation of medial prefrontal cortex (MPC), the effects of this treatment will be compared to the effects of the same treatment aiming the dorsolateral prefrontal cortex (DLPFC), also involved in aspects of negative symptoms of schizophrenia, and placebo effects induced by sham stimulation (using a sham coil). An anatomical MRI will be performed before the treatment to define the targets. Moreover, changes motor activity will be observed after stimulation thanks to continuous actimetry recording.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Social Cognition in Patients With Schizophrenia
Keywords
theta burst stimulation, Social Cognition, Schizophrenia, transcranial magnetic stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
61 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
TBS-MPC
Arm Type
Experimental
Arm Description
Intervention with Magstim® Active TBS aiming Medial Prefrontal Cortex in 18 patients with schizophrenia
Arm Title
TBS-CPDLF
Arm Type
Active Comparator
Arm Description
Intervention with Magstim® Active TBS aiming Dorsolateral Prefrontal Cortex in 18 patients with schizophrenia
Arm Title
TBS-Sham
Arm Type
Sham Comparator
Arm Description
Intervention with Magstim® Sham TBS in 25 patients with schizophrenia
Intervention Type
Device
Intervention Name(s)
Magstim® Active TBS
Intervention Description
Non-invasive transcranial magnetic stimulation inducing changes in cortical excitability depending on the cortical target (except for sham stimulation)
Intervention Type
Device
Intervention Name(s)
Magstim® Sham TBS
Intervention Description
Sham stimulation
Primary Outcome Measure Information:
Title
V-LIS total score
Time Frame
change from baseline in V-LIS total score compared to 30 days after the end of the treatment
Secondary Outcome Measure Information:
Title
Motor activity measured with an actimeter
Time Frame
change in baseline motor activity measured with an actimeter compared to 30 days after the end of the treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: with a diagnosis of schizophrenia or schizoaffective disorder (DSM-IV MINI R) Having signed a written informed consent 'Lecture Intentionnelle en situation' (LIS) score > 15 or negative 'Positive and Negative Syndrome Scale' (PANSS) score > 15 Exclusion Criteria: Any change in psychotropic drugs (antidepressants, antipsychotics or mood stabilizers) during the two months preceding the inclusion Pregnant or breastfeeding women Subjects with a neurological condition or with epilepsy Subjects with a counter-indication to MRI or Transcranial stimulation (electronic or metal implants) Subjects that refuse to wear earplugs during MRI
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sonia Dollfus, Pr
Phone
(0)231065018
Ext
+33
Email
dollfus@cyceron.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Céline Margrite
Phone
(0)231065018
Ext
+33
Email
margrite-c@chu-caen.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sonia Dollfus, Pr
Organizational Affiliation
University Hospital, Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dollfus
City
Caen
ZIP/Postal Code
14000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sonia Dollfus, Pr
Phone
+33231065018
Email
dollfus@cyceron.fr
First Name & Middle Initial & Last Name & Degree
Céline Margrite
Phone
+33231065018
Email
margrite-c@chu-caen.fr
First Name & Middle Initial & Last Name & Degree
Camille Delouche, MD
Facility Name
Jaafari
City
Poitiers
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nemat Jaafari, Pr
Email
nemat.jaafari@ch-poitiers.fr
Facility Name
Guillin
City
Sotteville-lès-Rouen
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olivier Guillin, Pr
Email
olivier.guillin@ch-lerouvray.fr

12. IPD Sharing Statement

Learn more about this trial

Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study

We'll reach out to this number within 24 hrs